MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer

References

• Ahmed FE. (2007). Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn 7:569–603
   PubMed Web of Science ®Google Scholar
• Association WM. (2000). Declaration of Helsinki, ethical principles for medical research involving human subjects. 52nd WMA General Assembly, Edinburgh, Scotland
   Google Scholar
• Bast RC Jr, Klug TL, St John E, et al. (1983). A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–7
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999–3004
   PubMed Web of Science ®Google Scholar
• Cui L, Zhang X, Ye G, et al. (2013). Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer 119:1618–26
   PubMed Web of Science ®Google Scholar
• Danaei G, Vander Hoorn S, Lopez AD, et al. (2005). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366:1784–93
   PubMed Web of Science ®Google Scholar
• Dunnwald LK, Rossing MA, Li CI. (2007). Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9:R6
   PubMed Web of Science ®Google Scholar
• Ebert MP, Rocken C. (2006). Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol 18:847–53
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–917
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–14
   PubMed Web of Science ®Google Scholar
• Guo J, Miao Y, Xiao B, et al. (2009). Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24:652–7
   PubMed Web of Science ®Google Scholar
• Hiyoshi Y, Kamohara H, Karashima R, et al. (2009). MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 15:1915–22
   PubMed Web of Science ®Google Scholar
• Hobert O. (2008). Gene regulation by transcription factors and microRNAs. Science 319:1785–6
   PubMed Web of Science ®Google Scholar
• Holmström MB, Johansson M, Bergh A, et al. (2009). Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ 339:b3537. doi: 10.1136/bmj.b3537
   Google Scholar
• Iorio MV, Croce CM. (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4:143–59
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Kimura M, Takeyama H. (2014). Role of microRNAs in gastric cancer. World J Gastroenterol 20:5694–9
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin 61:69–90
   PubMed Web of Science ®Google Scholar
• Jiang Z, Guo J, Xiao B, et al. (2010). Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 45:17–23
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Leung N, Cheng P, et al. (1997). ‘Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. Br J Cancer 75:236–40
   PubMed Web of Science ®Google Scholar
• Konishi H, Ichikawa D, Komatsu S, et al. (2012). Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer 106:740–7
   PubMed Web of Science ®Google Scholar
• Li PF, Chen SC, Xia T, et al. (2014). Non-coding RNAs and gastric cancer. World J Gastroenterol 20:5411–19
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu L, Liu B, et al. (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316:196–203
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435:834–8
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Wehbe-Janek H, et al. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647–58
   PubMed Web of Science ®Google Scholar
• Moriyama T, Ohuchida K, Mizumoto K, et al. (2009). MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 8:1067–74
   PubMed Web of Science ®Google Scholar
• Pineles BL, Romero R, Montenegro D, et al. (2007). Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196:261.e1–6
   PubMed Web of Science ®Google Scholar
• Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20:515–24
   PubMed Web of Science ®Google Scholar
• Yanagawa T, Hayashi Y, Nishida T, et al. (1986). Immunohistochemical demonstration of carcinoembryonic antigen (CEA) on tissue sections from squamous cell head and neck cancer and plasma CEA levels of the patients. Int J Oral Maxillofac Surg 15:296–306
   PubMed Web of Science ®Google Scholar
• Zhang X, Cui L, Ye G, et al. (2012). Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumour Biol 33:2349–55
   PubMed Web of Science ®Google Scholar
• Zhou H, Guo JM, Lou YR, et al. (2010). Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 88:709–17
   PubMed Web of Science ®Google Scholar
• Zhou H, Xiao B, Zhou F, et al. (2012). MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers 17:104–10
   PubMed Web of Science ®Google Scholar